---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-041284"
form_type: "8-K"
ticker: "DMAA"
cik: "0002028614"
company_name: "Drugs Made In America Acquisition Corp."
filed_at: "2026-04-08T23:59:59+00:00"
generated_at: "2026-05-15T06:56:45.702846+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# DMAA signs LOI for de-SPAC merger with Power Analytics Global Corp at ~$1B valuation

## Summary
- Non-binding letter of intent signed April 7, 2026, with target Power Analytics Global Corp (Delaware).
- Implied equity valuation of approximately $1.0 billion, subject to due diligence and adjustments.
- Minimum cash condition expected in range of $25 million to $50 million, subject to redemptions.
- Parties will negotiate definitive business combination agreement; deal to result in PAGC becoming public.
- DMAA may seek stockholder approval to extend business combination deadline; sponsor support possible.

## SEC filing metadata
- accession: 0001213900-26-041284
- form_type: 8-K
- ticker: DMAA
- cik: 0002028614
- company_name: Drugs Made In America Acquisition Corp.
- filed_at: 2026-04-08T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2028614/000121390026041284/0001213900-26-041284-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2028614/000121390026041284/ea0285527-8k_drugs.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-041284
- JSON: https://secwatch.observer/filing/0001213900-26-041284.json
- Plain text: https://secwatch.observer/filing/0001213900-26-041284.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.